Functional Neurological Disorder (FND) involves neurological symptoms arising from brain network changes rather than structural damage, often described as a “software” issue rather than a “hardware” problem. Symptoms…
Pompe disease is a progressive, life-threatening genetic neuromuscular disorder. Late-onset Pompe disease (LOPD), affecting individuals over one year old, leads to trunk and proximal muscle weakness, often impacting…
Ajay Verma, MD, PhD, Vice President, Translational Neurology, Biogen Inc., assesses the neurodegeneration problem that will accompany the significant increase in the elderly population. He discusses the imminent intersection…
Neil K. Warma, President & CEO, Opexa Therapeutics, delves into Opexa’s Phase 2B ABILI-T Clinical Trial for secondary progressive multiple sclerosis (MS) that expects to yield top-line results in 2016. Previous studies showed that with…
Jose Cavazos, MD, Professor of Medicine – Neurology & Physiology, Associate Professor of Pharmacology at University of Texas Health Science Center at San Antonio, discusses responsive neurological stimulation…
Selim R. Benbadis, MD, Director, Comprehensive Epilepsy Program, University of South Florida and Tampa General Hospital, discusses a common problem in reading EEGs: over-reading or misreading a normal…
Jason Silva, host of National Geographic’s Brain Games, introduces a new campaign, MS Visionaries, which will be featured in the Yahoo Health Portal. The program highlights visionaries who are…
Neil K. Warma, President & CEO, Opexa Therapeutics, discusses how Opexa’s research into the first personalized therapy for patients with multiple sclerosis (MS) could have much broader applications as a platform technology.…
Neil K. Warma, President & CEO, Opexa Therapeutics, gives background on what he means by “personalized therapy”. In contrast to the “sledgehammer effect” that current oral multiple sclerosis (MS) have…
Neil K. Warma, President & CEO, Opexa Therapeutics, explains Opexa’s goal to create the first personalized therapy for patients with multiple sclerosis. He discusses the ABILI-T Phase 2 Clinical…
People who develop fibromyalgia may complain of fatigue, memory problems and disturbances with sleep and mood. Fibromyalgia is often hard to diagnose and treat because there is not…
Ajay Verma, MD, PhD, VP of Translational Neurology at Biogen Inc., explains that we may have some of the technologies to answer the most challenging question of how…
